The plant cell growth company

Plant-Based Technology is the future, and our sustainable bioFarming technology enables us to produce specific types of plant cells without having to grow the entire plant.  We have a robust product pipeline that will deliver finger-print consistent, higher-quality, and lower-cost ingredients for pharmaceutical, nutraceutical, and health supplement products.

BioHarvest Sciences has a clear Path to Commercialization:

  • Targeting 1H 2022 for first sales of cannabis product

  • July 15, 2021 – Released inaugural Environmental, Sustainability and Governance (ESG) Report

  • May 2021 – Successful U.S. Vinia ecommerce launch

  • Q3 2021 – 20 Ton Production facility for Vinia to be online (Currently at 2 Tons per year capacity)

  • March  2021 -Unveiled Upcoming Olive based Nutraceutical for 2022

  • February 9, 2021 – Announced ability to optimize Trichome growth across multiple cannabis strains

  • December 2020 – First significant B2B US sale announced with Designs For Health and Batory Foods

  • Q4 2020 – Vinia Israel e-commerce launch exceeds projections

  • September 2020 – US Distribution agreement with Batory Foods for up to $18 Million of Vinia over 7 years

  • Patented technology

  • Proven Management team on both Product Development and Commercialization

  • Low Cap Ex alternative to traditional agriculture that will allow scalable production of ingredients such as hemp based CBD, grape, olive, and pomegranate products

Recent News Releases

Investor Inquiries

Join The Revolution

  • This field is for validation purposes and should be left unchanged.